BNP Paribas Knock-Out CLN/ DE000PC68M53 /
18/06/2024 09:21:04 | Var.+0.160 | Denaro10:14:00 | Lettera10:14:00 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
2.170EUR | +7.96% | 2.140 Quantità in denaro: 10,000 |
2.150 Quantità in lettera: 10,000 |
CLARIANT N | 11.7337 CHF | 31/12/2078 | Call |
GlobeNewswire
10:01
Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD ...
GlobeNewswire
10:00
VSTS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Vestis Corporation Investors w...
GlobeNewswire
10:00
FSLY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fastly, Inc. Investors with Su...
GlobeNewswire
10:00
HRBR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Harbor Diversified, Inc. Inves...
GlobeNewswire
10:00
AXTI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AXT Inc Investors with Substan...
GlobeNewswire
10:00
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with ...
GlobeNewswire
10:00
Nokia and Google Cloud collaborate to help developers worldwide create 5G applications faster with t...
GlobeNewswire
09:55
Nxera Pharma Publishes its Annual and ESG Reports for the Year ended 31 December 2023
GlobeNewswire
09:32
Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Smal...
GlobeNewswire
09:30
NewHydrogen CEO Steve Hill Discusses Green Hydrogen Future with UC Berkeley Economist
GlobeNewswire
09:08
Flash News: OKX Wallet Collaborates with BladeSwap and SynFutures to Launch Second Phase of 'Blast S...
GlobeNewswire
09:00
Precision-Panc Team Open the PRIMUS-006 Study, a Novel Combination of IMM-101, Gemcitabine and Pembr...
GlobeNewswire
09:00
Signify delivers plan to reduce greenhouse gas emissions by 90% across its entire value chain and re...
GlobeNewswire
09:00
Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for...